Methylphenidate
mph, ritalin, concerta, biphentin
Stimulant, Habit-forming, Common
A psychostimulant widely used worldwide as a first-line treatment for ADHD and used in the treatment of narcolepsy. Methylphenidate acts primarily as a norepinephrine–dopamine reuptake inhibitor (NDRI). In many European countries it is commonly prescribed as a first-line option for ADHD where amphetamine-based medications are less frequently used. It has been investigated for off-label use in stimulant dependence, but this is not standard clinical practice.
Moderate orange yellow
Chart shows bounded mass ranges in mg. See the table for all doses.
Light
Common
Strong
Heavy
Insufflated
5-10mg
10-20mg
20-30mg
30mg+
Oral
5-10mg
10-20mg
20-40mg
40mg+
Onset
Duration
Insufflated
5m to 10m
2 to 4
Oral_ER
30m to 2
8 to 12
Oral_IR
30m to 2
3 to 6
Oral
Increased alertness, Euphoria, Increased motivation, Reduced appetite, Flushing of the face, Increased body temperature, Tachycardia (increased heart rate), Paranoia, Insomnia
A chemical ionization selected ion monitoring assay for methylphenidate and ritalinic acid - http://www.ncbi.nlm.nih.gov/pubmed/526558Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (Ritalin): findings on chest radiographs and CT scans. - http://www.ncbi.nlm.nih.gov/pubmed/8109495Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol. - https://www.ncbi.nlm.nih.gov/pubmed/10820132A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during... - https://www.ncbi.nlm.nih.gov/pubmed/22289608Methylphenidate and brain dopamine neurotoxicity. - http://www.ncbi.nlm.nih.gov/pubmed/9365033Methylphenidate treatment induces oxidative stress in young rat brain. - http://www.ncbi.nlm.nih.gov/pubmed/16494852A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. - http://www.ncbi.nlm.nih.gov/pubmed/17201613Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity. - http://www.ncbi.nlm.nih.gov/pubmed/17218796Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder - http://www.ncbi.nlm.nih.gov/pubmed/19877980Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction - http://www.ncbi.nlm.nih.gov/pubmed/24261661Object memory impairment at post-drug Day 15 but not at Day 1 after a regimen of repeated treatment with oral methylphenidate. - http://www.ncbi.nlm.nih.gov/pubmed/24631430Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats. - http://www.ncbi.nlm.nih.gov/pubmed/26509840A chemical ionization selected ion monitoring assay for methylphenidate and ritalinic acid. - http://www.ncbi.nlm.nih.gov/pubmed/526558A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the w... - https://www.ncbi.nlm.nih.gov/pubmed/22289608Methylphenidate and brain dopamine neurotoxicity. - https://www.ncbi.nlm.nih.gov/pubmed/9365033Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a random... - http://www.ncbi.nlm.nih.gov/pubmed/19877980Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefronta... - http://www.ncbi.nlm.nih.gov/pubmed/26509840IV use of methylphenidate can lead to infections and abscesses due to the fillers in the medication - http://onlinelibrary.wiley.com/doi/10.1002/hed.2890060409/fullPregnancy category C according to the FDA - http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/010187s069,018029s040,021284s011lbl.pdfRitalin (methylphenidate) dosage information for adults and pediatric patients. Describes standard oral dosing, starting doses, titration schedules, and a recommended maximum total daily dose of 60 mg, administered in divided doses. - https://www.drugs.com/dosage/ritalin.htmlNHS guidance on how and when to take methylphenidate for adults. Covers standard tablet dosing, starting doses (5 mg), dose escalation, narcolepsy dosing, and maximum daily dose recommendations, with emphasis on divided dosing. - https://www.nhs.uk/medicines/methylphenidate-adults/how-and-when-to-take-methylphenidate-for-adults/Mayo Clinic clinical reference for oral methylphenidate. Provides dosing information for short-acting tablets in adults and children, including typical daily dose ranges, divided administration, and a recommended maximum daily dose of 60 mg. - https://www.mayoclinic.org/drugs-supplements/methylphenidate-oral-route/description/drg-20068297Riatlin works on Norepinephrine–dopamine reuptake inhibitor (NDRI) mechanism - https://en.wikipedia.org/wiki/Methylphenidate